DUBLIN, Calif., May 15 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapiddevelopment and commercialization of therapies for solid tumors andhematological malignancies, today announced that James S. Manuso, Ph.D.,President and Chief Executive Officer, is scheduled to present at the CitiInvestment Research Global Healthcare Conference on May 22, 2008 at the HiltonHotel in New York.
SuperGen's presentation at the Citi Investment Research Global HealthcareConference is scheduled to begin at 3:00 p.m. EDT (12:00 p.m. PDT). A livewebcast of the presentation will be available on the investor relationssection of the Company's Web site at www.supergen.com. A webcast replay ofthe presentation will be available for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery, rapid development and commercialization oftherapies for solid tumors and hematological malignancies. SuperGen isdeveloping a number of therapeutic anticancer products focused on kinase andcell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts Timothy L. Enns SuperGen, Inc. SVP, Corporate Communications & Business Development Tel: (925) 560-0100 E-mail: [email protected]
Mary M. Vegh SuperGen, Inc. Manager, Investor Relations Tel: (925) 560-2845 E-mail: [email protected]
SOURCE SuperGen, Inc.